Evaluation of cardiac toxicity of idarubicin (4-demethoxydaunorubicin)
- 1 January 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (1) , 13-18
- https://doi.org/10.1016/0277-5379(89)90045-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- CLINICAL-EVALUATION OF THE CARDIAC TOXICITY OF 4'-DEOXY-DOXORUBICIN1988
- PHASE-II STUDY OF IDARUBICIN GIVEN ORALLY IN THE TREATMENT OF ANTHRACYCLINE-NAIVE ADVANCED BREAST-CANCER PATIENTS1987
- Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicityAmerican Heart Journal, 1983
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Antileukemic Activity of 4-Demethoxydaunorubicin in MiceTumori Journal, 1980
- INVIVO LABELING OF RED BLOOD-CELLS WITH TC-99M - NEW APPROACH TO BLOOD POOL VISUALIZATION1977
- SYNTHESIS AND ANTITUMOR ACTIVITY OF 4-DEMETHOXYDAUNORUBICIN, 4-DEMETHOXY-7,9-DIEPIDAUNORUBICIN, AND THEIR BETA-ANOMERS1976
- Bedside technics for the evaluation of ventricular function in manThe American Journal of Cardiology, 1969